HighTower Advisors LLC Buys 1,013 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

HighTower Advisors LLC increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 10.6% in the fourth quarter, Holdings Channel.com reports. The fund owned 10,600 shares of the company’s stock after acquiring an additional 1,013 shares during the quarter. HighTower Advisors LLC’s holdings in Neurocrine Biosciences were worth $1,447,000 at the end of […]